Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.

NCT ID: NCT00227214

Last Updated: 2010-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-01-31

Study Completion Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine the prevalence of pneumococcal meningitis in the paediatric population in Spain four years after the marketing of Prevenar. Also secondary objectives are: 1) to determine the clinical characteristics and outcome of the disease; and 2) to determine serotypes and antibiotic resistance patterns.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumococcal Meningitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All children from 0 up to 14 years with diagnosis of confirmed or probable pneumococcal meningitis or with diagnosis of suspected bacterial meningitis without bacterial or viral isolation will be included into the study.
Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Wyeth is now a wholly owned subsidiary of Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

A Coruña, , Spain

Site Status

Alcalá de Henares, , Spain

Site Status

Alcorcón, , Spain

Site Status

Arrasate / Mondragón, , Spain

Site Status

Badalona, , Spain

Site Status

Barakaldo, , Spain

Site Status

Barcelona, , Spain

Site Status

Barco de Valdeorras, , Spain

Site Status

Bilbao, , Spain

Site Status

Boadilla del Monte, , Spain

Site Status

Cee, , Spain

Site Status

El Escorial, , Spain

Site Status

Esplugues de Llobregat, , Spain

Site Status

Estella-Lizarra, , Spain

Site Status

Ferrol, , Spain

Site Status

Figueres, , Spain

Site Status

Getafe, , Spain

Site Status

Girona, , Spain

Site Status

Granollers, , Spain

Site Status

Leganés, , Spain

Site Status

Lleida, , Spain

Site Status

Lugo, , Spain

Site Status

Madrid, , Spain

Site Status

Monforte de Lemos, , Spain

Site Status

Móstoles, , Spain

Site Status

Ourense, , Spain

Site Status

Pamplona, , Spain

Site Status

Pontevedra, , Spain

Site Status

Reus, , Spain

Site Status

Ribeira, , Spain

Site Status

Sabadell, , Spain

Site Status

San Sebastián, , Spain

Site Status

Tarragona, , Spain

Site Status

Terrassa, , Spain

Site Status

Tudela, , Spain

Site Status

Verín, , Spain

Site Status

Vigo, , Spain

Site Status

Vitoria-Gasteiz, , Spain

Site Status

Zumarraga, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0887X-101539

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.